AstraZeneca Claims FDA Skirted Seroquel Exclusivity
AstraZeneca PLC asked a Washington federal judge on Wednesday to vacate U.S. Food and Drug Administration approval of generic versions of its antipsychotic medication Seroquel, arguing the FDA's approval violated the...To view the full article, register now.
Already a subscriber? Click here to view full article